新型冠状病毒肺炎诊治要点浅析

doi:10.3969/j.issn.2095-3755.2020.01.003

结核病与肺部健康杂志 ›› 2020, Vol. 9 ›› Issue (1): 7-10.doi: 10.3969/j.issn.2095-3755.2020.01.003

新型冠状病毒肺炎诊治要点浅析

邓国防, 雷建平()

518112 国家感染性疾病临床医学研究中心深圳市第三人民医院肺二科(邓国防);江西省胸科医院结核科(雷建平)

收稿日期:2020-03-10 出版日期:2020-03-30 发布日期:2020-04-17
通信作者: 邓国防,雷建平 E-mail:lei-jianping@vip.sina.com

Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)

DENG Guo-fang, LEI Jian-ping()

^*National Clinical Research Center for Infectious Disease, Pulmonary Diseases Department Two, Shenzhen Third People’s Hospital, Shenzhen 518112, China

Received:2020-03-10 Online:2020-03-30 Published:2020-04-17
Contact: DENG Guo-fang,LEI Jian-ping E-mail:lei-jianping@vip.sina.com

摘要/Abstract

摘要：

当前新型冠状病毒肺炎(简称“新冠肺炎”)在中国引起严重疫情,而且对世界公共卫生造成巨大压力。截至发稿之日,全国确诊人数已逾8万例,全球超过10万例。为更好地增强临床医师对新冠肺炎的认识,我们结合新冠肺炎临床一线的救治体会、相关发表的研究文献和最近的诊疗方案,给大家简要概述新冠肺炎的诊治要点。期望能给临床医生提供一定的参考作用。

关键词: 新型冠状病毒肺炎, 诊断,鉴别, 疾病特征, 药物疗法, 方案评价, 评论

Abstract:

The novel coronavirus pneumonia (also named as coronavirus disease 2019 (COVID-19) By WHO) has been causing a severe public health problem in China. Now the epidemic has been posing great emergency not only in China, but also to the public health system worldwide. More than 80000 confirmed cases in China and more than 100000 confirmed cases worldwide have been reported at the day of this manuscript. For enhancing the clinicians’ understanding of COVID-19, we briefly summarized some main points of diagnosis and treatment from our experiences of COVID-19 patients care, literature review and recent diagnosis and treatment regimen. We hope to provide some references to clinicians when taking care of COVID-19 patients.

Key words: Coronavirus disease 2019 (COVID-19), Diagnosis, differential, Disease attributes, Drug therapy, Program evaluation, Comment

邓国防, 雷建平. 新型冠状病毒肺炎诊治要点浅析[J]. 结核病与肺部健康杂志, 2020, 9(1): 7-10. doi: 10.3969/j.issn.2095-3755.2020.01.003

DENG Guo-fang, LEI Jian-ping. Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)[J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 7-10. doi: 10.3969/j.issn.2095-3755.2020.01.003

参考文献 13

[1]	World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance[EB/OL]. 2020- 01- 28. [2020-01-30]. .
[2]	中华人民共和国国家卫生健康委员会办公厅,中华人民共和国国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]. 国卫办医函〔2020〕184号. 2020- 03- 03. [2020-03-05]. .
[3]	Xu Z, Shi L, Wang Y , et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020. pii: S2213-2600(20)30076-X. doi: 10.1016/S2213-2600(20) 30076-X.[Epub ahead of print].
[4]	Wang D, Hu B, Hu C , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020. doi: 10.1001/jama.2020.1585.[Epub ahead of print].
[5]	Luo W, Yu H, Gou J , et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)[J/OL]. Preprints,2020: 2020020407. 2020-02-17. [2020-02-26]. .
[6]	Chen N, Zhou M, Dong X , et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020,395(10223):507-513.
[7]	Guo L, Wei D, Zhang X , et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Front Microbiol, 2019,10:2752. doi: 10.3389/fmicb.2019.02752.eCollection 2019.
[8]	Li Q, Guan X, Wu P , et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020. doi: 10.1056/NEJMoa2001316.[Epub ahead of print].
[9]	Huang C, Wang Y, Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020,395(10223):497-506.
[10]	Chan JF, Yuan S, Kok KH , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020,395(10233):514-523.
[11]	刘又宁 . 关于新型冠状病毒感染疾病治疗药物的思考[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-18.[2020-02-26]. .
[12]	赵建平, 胡轶, 杜荣辉 , 等. 新型冠状病毒肺炎糖皮质激素使用的建议[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-08.[2020-02-26]. .
[13]	高占成, . 科学认识和科学管理是防控和救治新型冠状病毒肺炎的关键 [J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-05. [2020-02-21]. .

[1]	常丽, 任宏, 关雪晴, 庞有铨, 甄春英, 边楠楠, 孙素芹. 恶性胸腔积液患者血管内皮生长因子表达水平与疗效相关性研究[J]. 结核与肺部疾病杂志, 2024, 5(6): 533-539.
[2]	赖敏, 吴桂辉, 陈洪德, 李洪梅, 郭周莉, 王新伟. 28例体外受精-胚胎移植后妊娠并发结核病患者临床特征及母婴结局[J]. 结核与肺部疾病杂志, 2024, 5(6): 540-545.
[3]	刘伟坚, 徐宇翔, 詹森林, 张培泽, 覃红娟. 结核病专科医院活动性结核病死亡患者及其不同年龄组临床特征分析[J]. 结核与肺部疾病杂志, 2024, 5(5): 445-452.
[4]	仵倩红, 张燕, 刘鑫. 多学科持续发力终结结核病流行[J]. 结核与肺部疾病杂志, 2024, 5(4): 279-282.
[5]	蔡晓婷, 伍小英, 何立乾, 江坤洪. 家庭医生签约服务与肺结核患者临床特征的关联性研究[J]. 结核与肺部疾病杂志, 2024, 5(4): 333-338.
[6]	张悦, 朱晓筱, 顾芬. 慢性阻塞性肺疾病患者综合护理管理的机遇与挑战[J]. 结核与肺部疾病杂志, 2024, 5(3): 187-190.
[7]	牛佩璇, 阿尔泰, 李媛媛, 关文龙, 郑甜, 苏东栋, 杜清清, 杜彩云. 2018—2022年新疆维吾尔自治区肺外结核住院患者流行病学特征分析[J]. 结核与肺部疾病杂志, 2024, 5(1): 51-57.
[8]	王玉香, 胡秋萌, 郑俊峰, 邓国防, 张培泽. 堪萨斯分枝杆菌肺病与胞内分枝杆菌肺病临床特征及预后分析[J]. 结核与肺部疾病杂志, 2023, 4(6): 480-485.
[9]	尼尔佳玛丽·木塔力甫, 玛力亚·牙生, 克丽别娜·吐尔逊. 支气管哮喘气道炎症表型临床特征及靶向治疗研究进展[J]. 结核与肺部疾病杂志, 2023, 4(6): 506-510.
[10]	郭晶, 娄南南, 李佳琳, 张华, 马香. 胸闷变异性哮喘与典型哮喘的研究进展[J]. 结核与肺部疾病杂志, 2023, 4(5): 413-418.
[11]	王瑶, 刘敏, 胡智敏, 余盼丽, 吴鸣镝, 靖秋生. 支气管镜下肺癌病理类型及影像学特征分析[J]. 结核与肺部疾病杂志, 2023, 4(4): 301-307.
[12]	周林, 刘二勇, 赵雁林. 选择适宜治疗方案正确评估抗结核治疗疗效提高利福平敏感结核病治疗质量[J]. 结核与肺部疾病杂志, 2023, 4(3): 189-193.
[13]	杨翠, 李圆, 何振涛, 徐佳兴, 余晓滢, 卢成瑜, 陈德晖, 翟莺莺. DNAAF3突变引发原发性纤毛运动障碍一例并文献复习[J]. 结核与肺部疾病杂志, 2023, 4(2): 147-152.
[14]	李锡容, 谢佳星. 开展哮喘的多学科管理提高哮喘的诊治水平[J]. 结核与肺部疾病杂志, 2023, 4(2): 93-97.
[15]	王国卫, 梁亚充, 刘宇飞, 李翠乔, 何萍. 消瘰散结散联合常规抗结核药物治疗浸润型淋巴结结核的疗效观察[J]. 结核与肺部疾病杂志, 2023, 4(1): 60-65.

新型冠状病毒肺炎诊治要点浅析

Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 13

相关文章 15

编辑推荐

Metrics

本文评价

友情链接